| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 216,122 | 209,929 | 206,302 | 227,335 | | Cost of Revenue | 38,649 | 46,027 | 44,177 | 49,267 | | | Gross Profit | 177,473 | 163,902 | 162,125 | 178,068 | | | Operating Expenses | | Research Development | 88,049 | 90,653 | 94,692 | 99,984 | | Selling General and Administrative | 97,014 | 105,671 | 113,229 | 130,817 | | Non Recurring | (175) | 18,528 | (520) | 1,362,951 | | Others | 2,726 | 2,828 | 3,140 | 5,526 | | | | Total Operating Expenses | 187,614 | 217,680 | 210,541 | 1,599,278 | | | | Operating Income or Loss | (10,141) | (53,778) | (48,416) | (1,421,210) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,286 | (2,533) | (6,149) | (12,197) | | Earnings Before Interest And Taxes | (7,224) | (56,311) | (54,565) | (1,434,352) | | Interest Expense | 7,278 | 7,266 | 7,048 | 2,559 | | Income Before Tax | (14,502) | (63,577) | (61,613) | (1,436,911) | | Income Tax Expense | (455) | 10,780 | 1,644 | 202,044 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,047) | (74,357) | (63,257) | (1,638,955) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,047) | (74,357) | (63,257) | (1,638,955) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,047) | ($74,357) | ($63,257) | ($1,638,955) |
|
1.48% Nasdaq 
Income Statement
